{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:44:56Z","timestamp":1792071896272,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psychoactive drugs frequently cause delirium adverse events in older adults. However, few data on the relationship between antidepressants and delirium are available. Here, we investigated the association between antidepressant prescription and pharmacovigilance reports of delirium in older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the World Health Organization\u2019s VigiBase\u00ae global pharmacovigilance database from 1967 to 2022, we performed a disproportionality analysis in order to probe the putative associations between each antidepressant class (non-selective monoamine reuptake inhibitors (NSMRIs), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), alpha-2-adrenergic receptor antagonists, and other antidepressants) and reports of delirium in people aged 65 or over. We calculated the reporting odds ratios (r-OR) and their 95% confidence interval ([95%CI]) with logistic regression models before and after adjustment for confounding factors. Secondary analyses were performed for each drug and within each class by age group (65-74, and 75 and over). We also studied the reports of concomitant delirium and hyponatremia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our main analysis included 87,524 cases of delirium. After adjustment for confounders, a significant association was found between delirium and all antidepressant classes other than SNRIs. Intraclass disparities were found for the association between the most frequently prescribed antidepressants and reports of delirium. An elevated risk of reports of concomitant delirium and hyponatremia was found for SSRIs (4.46 [4.01-4.96]), SNRIs (1.25 [1.07-1.46]), MAOIs (1.72 [1.41-2.09]), and the \u201cother antidepressants\u201d class (1.47 [1.30-1.65]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There was a significant association between reports of delirium and antidepressant classes (other than SNRIs). However, this association varied from one drug to another within a given antidepressant class. Moreover, this association could not always be explained by antidepressant-induced hyponatremia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-024-05022-0","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T07:02:41Z","timestamp":1720767761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association between antidepressant use and delirium in older adults: an analysis of the World Health Organization\u2019s global pharmacovigilance database"],"prefix":"10.1186","volume":"24","author":[{"given":"Elise-Marie","family":"Minoc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Villain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumia","family":"Benbrika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Descatoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Heraudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Sassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Martinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dolladille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Lelong-Boulouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"issue":"5","key":"5022_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/j.1532-5415.2007.01150.x","volume":"55","author":"GJ McAvay","year":"2007","unstructured":"McAvay GJ, Van Ness PH, Bogardus ST, Zhang Y, Leslie DL, Leo-Summers LS, et al. Depressive symptoms and the risk of incident delirium in older hospitalized adults. J Am Geriatr Soc. 2007;55(5):684\u201391.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"5022_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199903043400901","volume":"340","author":"SK Inouye","year":"1999","unstructured":"Inouye SK, Bogardus ST, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340(9):669\u201376.","journal-title":"N Engl J Med"},{"issue":"945","key":"5022_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/pgmj.2003.017236","volume":"80","author":"K Alagiakrishnan","year":"2004","unstructured":"Alagiakrishnan K, Wiens CA. An approach to drug induced delirium in the elderly. Postgrad Med J. 2004;80(945):388\u201393.","journal-title":"Postgrad Med J"},{"issue":"8","key":"5022_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/archinte.161.8.1099","volume":"161","author":"L Han","year":"2001","unstructured":"Han L, McCusker J, Cole M, Abrahamowicz M, Primeau F, Elie M. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161(8):1099\u2013105.","journal-title":"Arch Intern Med"},{"issue":"6","key":"5022_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","volume":"55","author":"L De Picker","year":"2014","unstructured":"De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BGC. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics. 2014;55(6):536\u201347.","journal-title":"Psychosomatics"},{"issue":"2","key":"5022_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/gerona\/glr084","volume":"67A","author":"DG Le Couteur","year":"2012","unstructured":"Le Couteur DG, McLachlan AJ, de Cabo R. Aging, drugs, and drug metabolism. J Gerontol A Biol Sci Med Sci. 2012;67A(2):137\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"5022_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1001\/archpsyc.60.7.664","volume":"60","author":"DS Charney","year":"2003","unstructured":"Charney DS, Reynolds CF, Lewis L, Lebowitz BD, Sunderland T, Alexopoulos GS, et al. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry. 2003;60(7):664.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"5022_CR8","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/med.21671","volume":"40","author":"M Protti","year":"2020","unstructured":"Protti M, Mandrioli R, Marasca C, Cavalli A, Serretti A, Mercolini L. New-generation, non-SSRI antidepressants: drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Med Res Rev. 2020;40(5):1794\u2013832.","journal-title":"Med Res Rev"},{"issue":"3","key":"5022_CR9","first-page":"1657","volume":"18","author":"C Dolladille","year":"2021","unstructured":"Dolladille C, Chr\u00e9tien B, Peyro-Saint-Paul L, Alexandre J, Dejardin O, Fedrizzi S, et al. Association between disease-modifying therapies prescribed to persons with multiple sclerosis and cancer: a WHO pharmacovigilance database analysis. Neurother J Am Soc Exp Neurother. 2021;18(3):1657\u201364.","journal-title":"Neurother J Am Soc Exp Neurother"},{"issue":"12","key":"5022_CR10","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1007\/s00415-019-09533-4","volume":"266","author":"CM Zipser","year":"2019","unstructured":"Zipser CM, Deuel J, Ernst J, Schubert M, Weller M, von K\u00e4nel R, et al. Predisposing and precipitating factors for delirium in neurology: a prospective cohort study of 1487 patients. J Neurol. 2019;266(12):3065\u201375.","journal-title":"J Neurol"},{"issue":"5","key":"5022_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1159\/000514298","volume":"67","author":"J Marquetand","year":"2021","unstructured":"Marquetand J, Bode L, Fuchs S, Ernst J, von K\u00e4nel R, Boettger S. Predisposing and precipitating factors for delirium in the very old (\u226580 Years): a prospective cohort study of 3,076 patients. Gerontology. 2021;67(5):599\u2013607.","journal-title":"Gerontology"},{"issue":"9920","key":"5022_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(13)60688-1","volume":"383","author":"SK Inouye","year":"2014","unstructured":"Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911\u201322.","journal-title":"Lancet"},{"key":"5022_CR13","unstructured":"R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http:\/\/www.R-project.org\/."},{"issue":"Suppl 17","key":"5022_CR14","first-page":"4","volume":"60","author":"HG Westenberg","year":"1999","unstructured":"Westenberg HG. Pharmacology of antidepressants: selectivity or multiplicity? J Clin Psychiatry. 1999;60(Suppl 17):4\u20138.\u00a0discussion 46-48.","journal-title":"J Clin Psychiatry."},{"key":"5022_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fphar.2019.00299","volume":"10","author":"PL Chazot","year":"2019","unstructured":"Chazot PL, Johnston L, Mcauley E, Bonner S. Histamine and delirium: current opinion. Front Pharmacol. 2019;10:299.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5022_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-0773.1985.tb01256.x","volume":"56","author":"L Aaltonen","year":"2009","unstructured":"Aaltonen L, Syv\u00e4lahti E, Iisalo E, Peltom\u00e4ki T. Anticholinergic activity in the serum of patients receiving maintenance amitriptyline or doxepin therapy. Acta Pharmacol Toxicol (Copenh). 2009;56(1):75\u201380.","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"issue":"4","key":"5022_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0190-9622(85)70092-8","volume":"12","author":"SL Greene","year":"1985","unstructured":"Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol. 1985;12(4):669\u201375.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5022_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0028-3908(83)90238-1","volume":"22","author":"JZ Nowak","year":"1983","unstructured":"Nowak JZ, Arrang JM, Schwartz JC, Garbarg M. Interaction between mianserin, an antidepressant drug, and central H1- and H2-histamine-receptors: in vitro and in vivo studies and radioreceptor assay. Neuropharmacology. 1983;22(3):259\u201366.","journal-title":"Neuropharmacology"},{"issue":"2","key":"5022_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00213-013-3146-1","volume":"230","author":"H Sato","year":"2013","unstructured":"Sato H, Ito C, Tashiro M, Hiraoka K, Shibuya K, Funaki Y, et al. Histamine H1 receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers. Psychopharmacology. 2013;230(2):227\u201334.","journal-title":"Psychopharmacology"},{"issue":"2","key":"5022_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0013-7006(07)91548-1","volume":"33","author":"C Jacquot","year":"2007","unstructured":"Jacquot C, David DJ, Gardier AM, S\u00e1nchez C. Escitalopram and citalopram: the unexpected role of the R-enantiomer. L\u2019Encephale. 2007;33(2):179\u201387.","journal-title":"L\u2019Encephale"},{"issue":"3","key":"5022_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0165-0327(99)00120-2","volume":"58","author":"JD Guelfi","year":"2000","unstructured":"Guelfi JD, Strub N, Loft H. Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial. J Affect Disord. 2000;58(3):201\u20139.","journal-title":"J Affect Disord."},{"issue":"11","key":"5022_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1097\/JGP.0b013e3180cc1ff5","volume":"15","author":"BG Pollock","year":"2007","unstructured":"Pollock BG, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR, et al. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2007;15(11):942\u201352.","journal-title":"Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry"},{"issue":"6","key":"5022_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","volume":"25","author":"FP Bymaster","year":"2001","unstructured":"Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2001;25(6):871\u201380.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"issue":"12","key":"5022_CR24","doi-asserted-by":"publisher","first-page":"e229221","DOI":"10.1136\/bcr-2019-229221","volume":"12","author":"SY Lim","year":"2019","unstructured":"Lim SY, Bodagh N, Scott G, Hill NE. Hyponatraemia: the importance of obtaining a detailed history and corroborating point-of-care analysis with laboratory testing. BMJ Case Rep. 2019;12(12):e229221.","journal-title":"BMJ Case Rep"},{"issue":"5","key":"5022_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.therap.2018.02.006","volume":"73","author":"M Rochoy","year":"2018","unstructured":"Rochoy M, Zakhem-Stachera C, B\u00e9n\u00e9 J, Berkhout C, Gautier S. Antid\u00e9presseurs et hyponatr\u00e9mie\u202f: revue de litt\u00e9rature et analyse cas\/non-cas dans la base nationale de pharmacovigilance fran\u00e7aise. Therapies. 2018;73(5):389\u201398.","journal-title":"Therapies"},{"issue":"5","key":"5022_CR26","doi-asserted-by":"publisher","first-page":"e011200","DOI":"10.1136\/bmjopen-2016-011200","volume":"6","author":"KB Leth-M\u00f8ller","year":"2016","unstructured":"Leth-M\u00f8ller KB, Hansen AH, Torstensson M, Andersen SE, \u00d8dum L, Gislasson G, et al. Antidepressants and the risk of hyponatremia: a Danish register-based population study. BMJ Open. 2016;6(5):e011200.","journal-title":"BMJ Open"},{"issue":"6","key":"5022_CR27","doi-asserted-by":"publisher","first-page":"681.e11","DOI":"10.1016\/j.genhosppsych.2013.04.020","volume":"35","author":"N Kate","year":"2013","unstructured":"Kate N, Grover S, Kumar S, Modi M. Bupropion-induced hyponatremia. Gen Hosp Psychiatry. 2013;35(6):681.e11-681.e12.","journal-title":"Gen Hosp Psychiatry"},{"issue":"12","key":"5022_CR28","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","volume":"19","author":"JE Salem","year":"2018","unstructured":"Salem JE, Manouchehri A, Moey M, Lebrun-Vignes B, Bastarache L, Pariente A, et al. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol. 2018;19(12):1579\u201389.","journal-title":"Lancet Oncol"},{"key":"5022_CR29","unstructured":"WHO. Newsroom - Fact sheets - Detail - Dementia. 2021. https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/dementia."}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05022-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T07:03:49Z","timestamp":1720767829000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05022-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5022"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05022-0","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"6 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In line with the French legislation on retrospective, anonymized studies of routine medical practice (MR-004), and in accordance with the European regulation of April 27, 2016 on the protection of individuals with regard to the processing of data to personal character, the study protocol was approved by a hospital committee (C.L.E.R.S Comit\u00e9 Local d\u2019Ethique de la Recherche en Sant\u00e9) with competency for research not requiring authorization by an Institutional Review Board (University of Caen Normandy (Caen, France); reference: 2646, dated July 15th, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"600"}}